To visit the old Ventura website, click here.
Ventura Wealth Clients Login here

NSEBSE
NSEBSE
noteThere is a 15-minute delay in the prices. To check out the live prices, log in to your Ventura account or open one today.
1D
1W
1M
1Y
3Y
5Y
Max
Open1,145.1
High1,176.7
Low1,145.1
Prev. Close1,173.4
Avg. Traded Price1,162.91
Volume37,46,782

MARKET DEPTH

info2
Total bid34.00
Total ask0.00
OrdersQtyBid
4341173.4
000
000
000
000
AskQtyOrders
000
000
000
000
000

HIGH/LOW

info2
1d
1w
1m
3m
52w

LOW/HIGH

1,145.1015 hours ago
1,176.7011 hours ago
arrow

LOWER/UPPER CIRCUITS

1,038.50
1,269.10
arrow
Max Healthcare Ins Ltd Stock performance
arrow

KEY OBSERVATIONS

info
positive
negative
neutral
noteAnnual Revenue,rose 28.65%, in the last year to ₹7,184.1 Cr. Its sector's average revenue growth for the last fiscal year was 16.1%.
noteAnnual Net Profit,rose 1.72% in the last year to ₹1,075.88 Cr. Its sector's average net profit growth for the last fiscal year was 91.1%.
noteQuarterly Revenue,rose 31.41% YoY to ₹2,064.08 Cr. Its sector's average revenue growth YoY for the quarter was 16.15%.
View more

LONG-TERM PRICE ANALYSIS

info
Stock return5Y CAGR : %
Net profit growth 5Y CAGR : %

STOCK RETURNS

info
Versus Nifty 50
1 w
+1.95%
vs
+0.81%
1 mth
-2.99%
vs
+0.77%
3 mth
-5.73%
vs
+0.49%
6 mth
+17.79%
vs
+11.38%
1 yr
+26.25%
vs
-1.24%
3 yr
+170.70%
vs
+43%
5 yr
+873.82%
vs
+116.03%

About the Max Healthcare Institute Limited

Max Healthcare Institute Limited is one of India’s leading private hospital networks with a 25-year history of delivering tertiary and quaternary care. As on March 31, 2025, the network comprised 22 healthcare facilities with a capacity of over 5,100 beds, supported by advanced technologies and multidisciplinary clinical teams. Beyond hospitals, the Company’s ecosystem includes Max@Home (home healthcare) across 15+ cities and Max Lab (diagnostics) in 50+ cities, expanding access to care beyond traditional settings. Its clinical strengths span oncology, cardiac sciences, neurosciences, orthopaedics, renal sciences, transplants and more, with robotic surgery and modern imaging platforms deployed across the network.

Geographically, Max Healthcare serves patients across Delhi NCR (including Saket, Rajendra Place, Patparganj, Shalimar Bagh, Dwarka, Vaishali, Gurugram, Panchsheel Park, Noida and Lajpat Nagar) as well as Mumbai, Mohali, Bathinda, Dehradun, Lucknow and Nagpur. The Group had 10 subsidiaries as on March 31, 2025, including one step-down subsidiary.

 

Business Segment of Max Healthcare Institute Limited

  • Oncology – 25.8% of revenue in FY 2024-25

  • Cardiac Sciences – 10.7% of revenue

  • Orthopaedics – 10.4% of revenue

 

Max Healthcare Institute Limited’s Key Management Team

  • Abhay Soi – Chairman and Managing Director

  • Yogesh Kumar Sareen – Senior Director and Chief Financial Officer

  • Dhiraj Aroraa – Senior Vice President – Company Secretary and Compliance Officer

  • Dr Sandeep Budhiraja – Group Medical Director

  • Dr Vivek Talaulikar – Director and Chief Operating Officer (Western Region)

  • Dr Mradul Kaushik – Senior Director – Operations and Planning and Chief Operating Officer (Cluster 1)

  • Col. Harinder Singh Chehal – Senior Director – Chief Operating Officer (Cluster 2)

  • Umesh Gupta – Senior Director – HR and Chief People Officer

  • Anas Abdul Wajid – Senior Director – Chief Sales and Marketing Officer

  • Gagan Palta – Director & General Counsel

 

Latest Updates on Max Healthcare Institute Limited

  • Inorganic expansion: The Company acquired Jaypee Healthcare Limited, making Max Super Speciality Hospital, Noida part of the network; Max Super Speciality Hospital, Dwarka commenced operations as an asset-light greenfield model.

  • Capacity pipeline: A new greenfield hospital is under development in Sector 56, Gurugram, with additional built-to-suit facilities planned in Mohali (Zirakpur), Thane and Pitampura; multiple brownfield bed additions are underway across Mohali, Mumbai, Saket, Patparganj, Lucknow, Nagpur, Dwarka, Vaishali and Noida.

  • Network scale and reach: As of March 31, 2025, the network stood at 22 facilities with over 5,100 beds; Max@Home operated in 15+ cities and Max Lab in 50+ cities, extending patient-centric services beyond hospitals.

  • Accreditations and awards: The network includes four JCI-accredited hospitals and multiple AACI/NABL/QAI recognitions; facilities and teams received honours such as Best Patient-centric Hospital and Best Oncology Centre during 2024–25.

External rating: CARE Ratings reaffirmed the Company’s long-term rating at CARE AA+ and short-term rating at CARE A1+.

personal

Grow your wealth with more research recommendations

+91

Frequently Asked Questions

Max Healthcare provides tertiary and quaternary healthcare services across specialities, supported by diagnostics, ambulatory care and home-based services through Max Lab and Max@Home.

As of March 31, 2025, the network comprised 22 healthcare facilities and over 5,100 beds across 11 Indian cities, with home healthcare in 15+ cities and diagnostics in 50+ cities.

The Company had 10 subsidiaries, including one step-down subsidiary, as on March 31, 2025.